ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Big Community Programs Under Way In Detroit, N.M.; Others Near OK

January 14, 1977

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

NCI “Community Cancer Centers” Program in Development, House Report Reveals.

June 30, 2006

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

AIDS Drug Discovery Groups RFA Draws 20 Applications

May 9, 1986

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002